Defibrillation Thresholds & Desmoplakin Cardiomyopathy

Defibrillation Thresholds and Desmoplakin Cardiomyopathy

Defibrillation Thresholds & Desmoplakin Cardiomyopathy

This infographic explores Defibrillation Thresholds (DFTs) and their importance in device management for cardiomyopathy patients, as well as the role of Desmoplakin (DSP) mutations in hereditary cardiomyopathy, especially ARVC. It covers the indications for DFT testing, causes of high DFTs, genetic implications in unexplained DCM cases, and diagnostic utility of imaging modalities like MRI and PET. The discussion highlights DSP cardiomyopathy’s arrhythmogenic potential and genetic considerations in familial DCM.

Produced by: Dr. Richard Ferraro
Graphics by: Dr. Karan Desai


CardioNerds Infographics

Explore our comprehensive collection of infographics, categorized by cardiovascular topics such as heart failure and transplantation, arrhythmias and electrophysiology, cardio-obstetrics, cardiovascular imaging, congenital heart disease, prevention, coronary artery disease, critical care, hypertension, pericardial disease, pulmonary hypertension, valvular heart disease, vascular disease, women’s cardiovascular health, diversity, inclusion, and more!

Feel free to download and share these visuals in presentations or on social media. Please use the infographics as provided—without altering or cropping out the creators’ credit.

For even more learning, explore the CardioNerds Tweetorial Page, featuring a curated collection of educational tweetorials!

You are currently viewing Defibrillation Thresholds & Desmoplakin Cardiomyopathy